#	Pagina
attuale pagina	/open-h2020/projects/209465/index.html

Opendata, web and dolomites

MOPEAD SIGNED

Models Of Patient Engagement for Alzheimer’s Disease - Sofia ref.: 115985

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

MOPEAD project word cloud

Explore the words cloud of the MOPEAD project. It provides you a very rough idea of what is the project "MOPEAD" about.

runs progress trials efforts eligible select pcc se model protocols scan science economic individuals pe cross rct evaluation prodromal subjects central significantly amyloid house pioneered epfia gap shift centre strategies biomarkers campaign mild stage methodology invited ad care burden ct consensus countries de paradigm clinical citizen mentioned mopead mci positive complementary assets baseline reducing tackle t2dm efficacy formal add brings exists cover builds possesses sl nl carefully prevention country aligned offers categories conventional diabetes holistic data patient setting risk metrics ohi screening confident expertise health healthcare patients enhanced engagement imi2 protocol successful es primary models border

Project "MOPEAD" data sheet

The following table provides information about the project.

Coordinator	FUNDACIO ACE Organization address address: MARQUES DE SENTMENAT 57 city: BARCELONA postcode: 8014 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Spain [ES]
Project website	http://www.mopead.eu
Total cost	4˙581˙967 €
EC max contribution	2˙043˙000 € (45%)
Programme	1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2))
Code Call	H2020-JTI-IMI2-2015-05-two-stage
Funding Scheme	IMI2-RIA
Starting year	2016
Duration (year-month-day)	from 2016-10-01 to 2019-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	FUNDACIO ACE FUNDACIO ACE Organization address address: MARQUES DE SENTMENAT 57 city: BARCELONA postcode: 8014 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (BARCELONA)	coordinator	311˙684.00
2	KAROLINSKA INSTITUTET KAROLINSKA INSTITUTET Organization address address: Nobels Vag 5 city: STOCKHOLM postcode: 17177 website: www.ki.se contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SE (STOCKHOLM)	participant	468˙701.00
3	GMV SOLUCIONES GLOBALES INTERNET SAU GMV SOLUCIONES GLOBALES INTERNET SAU Organization address address: CALLE ISAAC NEWTON 11 PARQUE TECNOLOGICO DE MADRID city: TRES CANTOS MADRID postcode: 28760 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (TRES CANTOS MADRID)	participant	380˙593.00
4	UNIVERZITETNI KLINICNI CENTER LJUBLJANA UNIVERZITETNI KLINICNI CENTER LJUBLJANA Organization address address: ZALOSKA CESTA 002 city: LJUBLJANA postcode: 1000 website: http://www.kclj.si/nuklearna contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SI (LJUBLJANA)	participant	168˙306.00
5	KLINIKUM DER UNIVERSITAET ZU KOELN KLINIKUM DER UNIVERSITAET ZU KOELN Organization address address: Kerpener Strasse 62 city: KOELN postcode: 50937 website: www.uk-koeln.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (KOELN)	participant	144˙106.00
6	ASDM CONSULTING ASDM CONSULTING Organization address address: RUE DE LA VIGNETTE 96 BOITE 9 city: AUDERGHEM postcode: 1160 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	BE (AUDERGHEM)	participant	118˙299.00
7	STICHTING VUMC STICHTING VUMC Organization address address: DE BOELELAAN 1117 city: AMSTERDAM postcode: 1081 HV website: www.vumc.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (AMSTERDAM)	participant	97˙347.00
8	ALZHEIMER EUROPE ALZHEIMER EUROPE Organization address address: RUE DICKS 14 city: LUXEMBOURG postcode: 1417 website: www.alzheimer-europe.org contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	LU (LUXEMBOURG)	participant	91˙275.00
9	MODUS RESEARCH AND INNOVATION LIMITED MODUS RESEARCH AND INNOVATION LIMITED Organization address address: 7-11 MELVILLE STREET city: EDINBURGH postcode: EH3 7PE website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (EDINBURGH)	participant	82˙143.00
10	FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA Organization address address: PASSEIG VALL D HEBRON 119-129 EDIFICIO DE RECERCA city: BARCELONA postcode: 8035 website: http://www.vhir.org/ contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (BARCELONA)	participant	74˙322.00
11	EUROPEAN INSTITUTE OF WOMEN'S HEALTH COMPANY LIMITED BY GUARANTEE EUROPEAN INSTITUTE OF WOMEN'S HEALTH COMPANY LIMITED BY GUARANTEE Organization address address: PEARSE STREET 33 city: DUBLIN postcode: 2 website: www.eurohealth.ie contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IE (DUBLIN)	participant	45˙688.00
12	KITE INNOVATION (EUROPE) LIMITED KITE INNOVATION (EUROPE) LIMITED Organization address address: 3M BUCKLEY INNOVATION CENTRE city: HUDDERSFIELD postcode: HD1 3BD website: www.kiteinnovation.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (HUDDERSFIELD)	participant	34˙538.00
13	SPOMINCICA ALZHEIMER SLOVENIJA SLOVENSKO ZDRUZENJE ZA POMOC PRI DEMENCI SPOMINCICA ALZHEIMER SLOVENIJA SLOVENSKO ZDRUZENJE ZA POMOC PRI DEMENCI Organization address address: LUIZE PESJAKOVE 9 city: LJUBLJANA postcode: 1000 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SI (LJUBLJANA)	participant	25˙991.00
14	ASTRAZENECA AB ASTRAZENECA AB Organization address address: Vastra Maelarhamnen city: SODERTAELJE postcode: 151 85 website: www.astrazeneca.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SE (SODERTAELJE)	participant	0.00
15	Eli Lilly and Company Limited Eli Lilly and Company Limited Organization address address: Lilly House, Priestley Road city: Basingstoke postcode: RG24 9NL website: www.lilly.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (Basingstoke)	participant	0.00

Map

Project objective

The MOPEAD consortium has proposed a programme of work carefully aligned to the objectives of IMI2 Call to deliver a step-change in AD-related patient engagement (PE) strategies and a paradigm shift in early stage care. It aims to improve patient engagement in three categories: 1) Pre-clinical AD (the most important for prevention trialsÍ¾ 2) Prodromal AD (i.e. MCI with positive amyloid biomarkers)Í¾ and 3) Very Mild AD. MOPEAD offers four different and complementary strategies, namely AD Citizen-Science, Open House Initiative (OHI), Primary Care Campaign (PCC), and Type 2 Diabetes (T2DM). It seeks subjects eligible for CT scan in all three mentioned categories. The central concept is to test and evaluate the four Patient Engagement models (Runs) to help identify patients at risk of AD in a five-country, multi-centre setting. It builds upon an already successful model, the Open House Initiative pioneered by the coordinator (FACE). Five countries (ES, DE, NL, SE and SL) have been selected to implement these models based upon relevant expertiseÍ¾ the consortium brings together partners for their potential to become long-term assets to European efforts to tackle AD challenges. The methodology involves enhanced pre-screening protocols to select individuals for conventional screening associated to an RCT. Eligible subjects will be invited to formal evaluation using a protocol consensus with EPFIA. MOPEAD possesses confident baseline metrics from which to measure progress and determine the efficacy of PE strategies compared to primary care. Although baseline data exists for only three of the four proposed models, the new model AD Citizen Science approach will add significantly to the holistic approach of the project. The proposal addresses the specific cross-border challenge of improving health care and reducing the economic burden related to AD by means of identifying those patients at risk of developing AD. This will cover a significant gap in the healthcare system.

Deliverables

List of deliverables.
End of project EU seminar	Other	2020-04-14 09:21:32
Public education / awareness raising strategies	Documents, reports	2020-04-14 09:21:26
Recommendations for policy makers and regulators	Documents, reports	2020-04-14 09:21:19
MOPEAD Outreach- Report on MOPEADâ€™s collaboration with other AD related projects and wider European Dementia stakeholders	Documents, reports	2020-04-14 09:21:11
EconomicÂ evaluationÂ report	Documents, reports	2020-04-14 09:21:05
Report on comparison and evaluation of efficacy of PE strategies in different countries	Documents, reports	2020-04-14 09:20:59
Anonymous Open Access database: MOPEADâ€™s raw data and results available for use by research community andÂ relevantÂ stakeholders	Documents, reports	2020-04-14 09:20:52
Common protocol of evaluation execution report	Documents, reports	2020-04-14 09:20:46
Primary Care campaign final execution report	Documents, reports	2020-04-02 09:37:02
Online campaign execution reports	Documents, reports	2020-04-02 09:36:54
Gender policy brief	Other	2020-04-02 09:37:18
Tertiary Care campaign final execution report	Documents, reports	2020-04-02 09:37:10
Open House campaign final execution report	Documents, reports	2020-03-17 14:22:59
Citizen Science Web design report	Documents, reports	2020-03-17 14:22:59
Primary Care campaign strategy report	Documents, reports	2020-03-17 14:22:59
Tertiary Care campaign strategy report	Documents, reports	2020-03-17 14:22:59
Online Campaign tactic plan report	Documents, reports	2020-03-17 14:22:59
Online campaign strategy report	Documents, reports	2020-03-17 14:22:59
Open House campaign strategy report	Documents, reports	2020-03-17 14:22:59
Leaflets for participants on cognitive health and lifestyle	Other	2020-03-17 14:22:59

Take a look to the deliverables list in detail: detailed list of MOPEAD deliverables.

Publications

List of publications.
year	authors and title	journal	last update
2019	Octavio RodrÃguez-GÃ³mez, AdriÃ¡n Rodrigo, FÃ¡tima Iradier, Miguel A. Santos-Santos, Hans Hundemer, Andreea Ciudin, Lena Sannemann, Marissa Zwan, Bridget Glaysher, Anders Wimo, Jaka Bonn, Gunilla Johansson, Isabel Rodriguez, Montse Alegret, Dianne Gove, Susana PinÃ³, Paloma Trigueros, Miia Kivipelto, Brandy Mathews, Antonio Ciudad, Daniel Ferreira, Christophe Bintener, Miren Gurruchaga, Eric West The MOPEAD project: Advancing patient engagement for the detection of â€œhiddenâ€ undiagnosed cases of Alzheimer\'s disease in the community published pages: 828-839, ISSN: 1552-5260, DOI: 10.1016/j.jalz.2019.02.003	Alzheimer\'s & Dementia 15/6	2020-03-17

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOPEAD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MOPEAD" are provided by the European Opendata Portal: CORDIS opendata.